Medical/Pharmaceuticals
Lifebit Awarded A Four-Year Contract for Hong Kong's Genome Project
Lifebit's precision medicine software will power Hong Kong's development of genomic medicine by supporting the Hong Kong Genome Institute to implement the first large-scale genome sequencing initiative, the Hong Kong Genome Project. The Project will empower medical professionals and researchers t...
2021-05-25 06:00
3087
Biovaxys Strengthens Internal Expertise With Appointment Of Scientific Advisor For Ovarian Cancer Vaccine Clinical Program And Papilocare Marketing
VANCOUVER, British Columbia, May 24, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA: 5LB, US OTCQB: BVAXF) ("BioVaxys" or "the Company") is pleased to announce thatCharles J. Dunton, MD, has joined BioVaxys as an Advisor to help provide additional scientific support for BVX-0918A,...
2021-05-24 20:00
6792
Akeso's Penpulimab Monoclonal Antibody Submitted BLA in the United States
HONG KONG, May 24, 2021 /PRNewswire/ -- On May 24, 2021, Akeso, Inc. (HKEx: 9926.HK) announced that Penpulimab (research and development code: AK105), an PD-1 monoclonal antibody drug co-developed by the Company with Sino Biopharmaceutical Limited (HKEx: 1177.HK), has submitted a Biologics Licens...
2021-05-24 18:17
2812
CanSinoBIO Receives European GMP Certification for its COVID-19 Vaccine Convidecia™
* A major step for introducing Convidecia™ to more countries and people in need for protection * Vaccine has been approved in China, Mexico, Pakistan, Hungary and Chile * Provides timely clinical protection for adults aged 18 and above, including those over 60 TIANJIN, China, May 24, 2021 /P...
2021-05-24 17:00
6003
5.20 Infinitus Social Responsibility Day 2021 aims to improve public heath
GUANGZHOU, China, May 24, 2021 /PRNewswire/ -- On May 20, Infinitus (China) Company Ltd. organized the 3rd 5.20 Infinitus Social Responsibility Day with the theme of "Promoting Chinese Culture of Health Maintenance, Supporting the Healthy China Initiative" at the company's production base in Xinh...
2021-05-24 17:00
405
Daewoong, first-in-class PRS-inhibitor for Idiopathic Pulmonary Fibrosis (IPF) shows promising result in early stage clinical test
* We confirmed the safety of 'DWN12088' and secured grounds for establishing treatment dosage * Confirming the potential as a treatment for IPF and planning to apply for Ph.2 within 2021 * 2nd ODD granted as treatment for systemic sclerosis from the US FDA SEOUL, South Korea, May 24, 2021 /...
2021-05-24 16:59
1569
Ko-Max to debut a new suction system with enhanced user interface
INCHEON, South Korea, May 24, 2021 /PRNewswire/ -- Aerosol Suction "Silence Series", Ko-Max's new, lighter suction system with better user interface than the conventional model is getting popular. Ko-Max announced that its Silence Series, released last month, is becoming popular in various secto...
2021-05-24 16:14
1476
Aiming for Zero Leprosy: 30th Anniversary of World Health Assembly Resolution and WHO Global Leprosy Strategy 2021-2030 Are Opportunities to Accelerate Efforts against the Disease
TOKYO, May 24, 2021 /PRNewswire/ -- Thirty years ago this month, the World Health Assembly (WHA) adopted a resolution to eliminate leprosy as a public health problem. Today, as the 74th WHA gets under way, WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa is urging countries not to o...
2021-05-24 15:00
1330
Luye Pharma's Innovative Alzheimer's Disease Therapy Rivastigmine Multi-Day Transdermal Patch Now Eligible for Marketing Authorization in Several EU Countries
MIESBACH, Germany and BASEL, Switzerland, May 24, 2021 /PRNewswire/ -- Luye Pharma Group today announced the successful completion of the Decentralised Registration Procedures (DCPs) for its Rivastigmine Multi-Day Transdermal Patch (Rivastigmine MD). With the end of procedure achieved on21 May 20...
2021-05-24 10:27
2908
Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID
SEOUL, Korea, May 24, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this year's European Congress of Clinical Microbiology, the ECCMID. Seegene's...
2021-05-24 09:58
1714
Poster to Highlight ENVASARC Pivotal Trial of Envafolimab (KN035) will be presented at the 2021 ASCO Annual Meeting
SUZHOU, China, May 24, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced the study design of the ENVASARC pivotal trial in the U.S. of Envafolimab (KN035), a recombinant humanized PD-L1 single domain antibody independently invented by Alphamab Oncology, will be presented by A...
2021-05-24 08:54
5762
Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea
Novavax and SK bioscience reaffirm partnership during meeting with South Korean leaders GAITHERSBURG, Md., May 23, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the signing of a non-...
2021-05-23 00:39
9151
Ortho Clinical Diagnostics Simultaneously Launches First Quantitative COVID-19 IgG Spike Antibody Test As Well As A Nucleocapsid Antibody Test to Help Differentiate Cause of Antibody Response
- Ortho is the only company that offers laboratories in the U.S. a quantitative test in combination with a nucleocapsid test - Both new antibody tests help health care teams differentiate the cause of antibodies against SARS-CoV-2 - Ortho's new VITROS® Anti-SARS-CoV-2 IgG Quantitative Antibody t...
2021-05-22 05:22
9475
Recently Merged dMed and Clinipace Announce the Appointment of New Global COO
SHANGHAI and MORRISVILLE, N.C., May 21, 2021 /PRNewswire/ -- Following the recent merger announcement ofShanghai-based dMed Global and NC-based Clinipace Incorporated, the combined company today announced the appointment ofSimon Britton to the position of Chief Operating Officer (COO). Britton w...
2021-05-21 20:00
5050
Blue Launches #WeSupport Campaign for Complimentary Post-Vaccination Protection
HONG KONG, May 21, 2021 /PRNewswire/ -- Blue, Hong Kong's first digital life insurer, launches the #WeSupport campaign to provide customers with extra free protection for post-vaccination. To safeguard customers and their families' health, and to ensure they can get vaccinated with assurance, eli...
2021-05-21 17:19
2590
/DISREGARD RELEASE: Seegene Inc./
We are advised by Seegene Inc. that journalists and other readers should disregard the news release, Seegene reports solid results in the first quarter of 2021 withKRW 351.8 billion, issued 12-May-2021 over PR Newswire....
2021-05-21 09:36
16286
Johnson & Johnson Medical Korea Ltd. and Johnson & Johnson Innovation LLC Announce Launch of Seoul Innovation QuickFire Challenge on Smart Surgery in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute
- QuickFire Challenge calls on innovators to submit novel ideas with the potential to transform the surgical pathway for optimized care, cost savings, and improved patient outcomes. - Awardee(s) will receive grant funding from a total of up to KRW150,000,0001 , one year of residency at the Seoul ...
2021-05-21 05:00
3268
BioVaxys Announces Appointment of Policy Advisor
VANCOUVER, BC, May 20, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTC:BVAXF)("BioVaxys"), a biotechnology company that is advancing viral and oncology vaccine platforms as well as immuno-diagnostic products, today announced the appointment ofAdam Coutts, PhD, as Policy ...
2021-05-20 20:00
11641
Everest Medicines Announces China NMPA Has Granted Priority Review for Sacituzumab Govitecan-hziy in Metastatic Triple-Negative Breast Cancer
SHANGHAI, May 20, 2021 /PRNewswire/ -- Everest Medicines
2021-05-20 19:04
5233
Invitation to Elekta's Capital Markets Day 2021
STOCKHOLM, May 20, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) invites investors, analysts and financial media representatives to join Elekta's digital Capital Markets Day (CMD) onJune 7, 2021. Speakers at the event will include Gustaf Salford, President and CEO,Johan Adebäck, CFO, and several other ...
2021-05-20 17:03
8564
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 296 media titles]
2024-11-28 17:24MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
[Picked up by 273 media titles]
2024-11-29 20:33
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
13075
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
9154
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
8279
